The company recently confirmed that it is developing a second carotenoid to complement its Phyt-N-Resist ingredient, an anti-ageing active that was launched in September.
The as yet to be named ingredient is being produced from a similar innovative carotenoid process employed for its other ingredient, which uses an exclusive fermentation process.
Although the company has confirmed that the ingredient is being developed for dermocosmetic applications, the company only reveals that it is for a specific application that is on the rise that cannot be revealed until the actual launch.
The company says that its R&D team has developed and optimized a proprietary bacteria strain for the optimal production of the new carotenoid.
Right now it is working on developing an extraction process that can ultimately be industrialized and then once validated it will progress beyond to pilot stage to a scaled-up full production.
Testing shows promise
The company says that in vitro tests already being carried out have shown promise and that once the final formulation is validated, the product will undergo full clinical trials.
"After the successful launch of Phyt-N-Resist, we are expanding our portfolio of proprietary active ingredients based on 100% pure carotenoids,” said Emmanuel Petiot, CEO of Deinove.
“Thanks to the combination of our biotechnological platform and our collection of rare micro-organisms, we alone are capable of producing these innovative molecules of natural origin and we are capitalizing on this expertise to develop a real portfolio of commercial high value-added active ingredients."